SPOTLIGHT -
Dr Elwood is the Disease Area Stronghold Lead for Neurodegeneration at Johnson & Johnson.
Posdinemab: Addressing the Unmet Need in Alzheimer Disease
Here's why you should be paying attention to this new, upcoming Alzheimer disease treatment...